Trial Profile
Pain Relief During Photodynamic Therapy for Actinic Keratoses With a New Irradiation Protocol
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 May 2017
Price :
$35
*
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Actinic keratosis
- Focus Therapeutic Use
- 09 May 2017 Status changed from active, no longer recruiting to completed.
- 07 Jan 2017 Planned End Date changed from 1 Dec 2016 to 1 Mar 2017.
- 07 Jan 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Mar 2017.